Reading Annual report last nifht, which reconfirms all trial timelines. So by 30th Jund 2019, Immuron will have published trial data on ASH, Pediatric NASH, Cdiff. Then with 3x NASH trial data will partner/commercialise NASH. So could be trading anything between $1-$3 or Nasdaq $IMRN equivalent of $30-$90.
- Forums
- ASX - By Stock
- IMC
- 30th June 2019
30th June 2019
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.5¢ | $1.158K | 11.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9352 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 251204 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9352 | 0.105 |
5 | 347605 | 0.100 |
1 | 52520 | 0.095 |
1 | 9695 | 0.092 |
2 | 145000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 111204 | 3 |
0.115 | 100000 | 2 |
0.120 | 193000 | 3 |
0.130 | 218736 | 6 |
0.140 | 105750 | 2 |
Last trade - 10.48am 27/08/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online